These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 10213221

  • 1. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P.
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [Abstract] [Full Text] [Related]

  • 2. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [Abstract] [Full Text] [Related]

  • 3. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.
    Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM, Appelt K.
    Ann N Y Acad Sci; 1999 Jun 30; 878():236-70. PubMed ID: 10415735
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM.
    Cancer Res; 2001 Dec 15; 61(24):8730-6. PubMed ID: 11751392
    [Abstract] [Full Text] [Related]

  • 5. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM.
    Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618
    [Abstract] [Full Text] [Related]

  • 6. AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
    Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN.
    Cancer Res; 2006 Sep 01; 66(17):8722-30. PubMed ID: 16951188
    [Abstract] [Full Text] [Related]

  • 7. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug 01; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

  • 8. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.
    Cancer Res; 2004 Nov 01; 64(21):7954-61. PubMed ID: 15520202
    [Abstract] [Full Text] [Related]

  • 9. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1546-57. PubMed ID: 17077357
    [Abstract] [Full Text] [Related]

  • 10. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L, Sunamura M, Kobari M, Egawa S, Ding L, Matsuno S.
    Cancer Res; 1999 Mar 15; 59(6):1252-8. PubMed ID: 10096556
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 12. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 15; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 13. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan 15; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

  • 14. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y.
    Life Sci; 2007 Sep 29; 81(16):1256-63. PubMed ID: 17919663
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT.
    Mol Pharmacol; 2006 Nov 29; 70(5):1524-33. PubMed ID: 16887936
    [Abstract] [Full Text] [Related]

  • 16. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA, Johnson MD, Bone EA, Dickson RB.
    Clin Cancer Res; 1996 Jul 29; 2(7):1207-14. PubMed ID: 9816289
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
    Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP, Rao JS.
    Oncogene; 2002 Nov 14; 21(52):8011-9. PubMed ID: 12439751
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y.
    Cancer Gene Ther; 2004 May 14; 11(5):325-32. PubMed ID: 15044958
    [Abstract] [Full Text] [Related]

  • 19. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C, Luddy C, Abounader R, Lal B, Laterra J.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):287-93. PubMed ID: 10873600
    [Abstract] [Full Text] [Related]

  • 20. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
    Narla RK, Chen CL, Dong Y, Uckun FM.
    Clin Cancer Res; 2001 Jul 24; 7(7):2124-33. PubMed ID: 11448932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.